Blurry, distorted vision is a common symptom of wet AMD (age-related macular degeneration). Your eyes may also have difficulty adjusting to changes in lighting.

Alliance/Market LaunchBio Usawa becomes partner for the commercialization of FYB201/ BioUcenta™ (ranibizumab) across Sub-Saharan Africa 01.07.2025 / 13:15 CET/CESTThe issuer is solely responsible for ...

First, although results of cell transplantation (through injection) are preliminary for the treatment of intervertebral disc degeneration, most studies showed that the transplanted cells could not ...

The European Commission has cleared the high-strength formulation of Eylea (aflibercept) with an extended treatment interval ...

It is designed to slow the progression of geographic atrophy, a severe form of age-related macular degeneration. This interventional study is non-randomized with a parallel assignment model.

Choroidal neovascularization in myopic macular degeneration can cause vision loss, but advances in treatment options may prevent that outcome for many. Learn more about these sight-saving therapies.

Adverse event rates following intravitreal injection of Avastin or Lucentis for treating age-related macular degeneration [abstract]. Invest Ophthalmol Vis Sci 2011;52:E-Abstract 6644.

Wet AMD is the less common type of age-related macular degeneration, which can result in a rapid loss of central vision in one or both eyes.

A new study suggests that measuring specific immune system proteins in the blood could help predict which patients with intermediate age-related macular degeneration (AMD) are most likely to ...

Christine A. Curcio, PhD, highlighted new findings on macular pigment imaging and its implications for age-related macular degeneration (AMD) at the Heidelberg 2025 International Spectralis Symposium ...